Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

International Journal of Cardiology
T SuehiroK Hashimoto

Abstract

We investigated the association of paraoxonase (PON) gene polymorphism with both the occurrence of coronary heart disease (CHD) and the severity of coronary artery stenosis in Japanese subjects. PON is a protein associated with plasma HDL. It has been hypothesized an A/B (Gln 192-->Arg) polymorphism of PON may be involved in the pathogenesis of CHD, especially among subjects with non-insulin-dependent diabetes mellitus (NIDDM). The polymorphism was determined in 134 patients with myocardial infarction (MI) or angina pectoris, and in 252 healthy subjects as controls. The frequencies of the AA, AB, and BB genotypes in the patients were 15, 50 and 35%, respectively, and these frequencies did not differ from those in control subjects (14, 49, and 37%). The relative risk of CHD was not found to be associated with these genotypes. These data also were similar among selected subgroups (patients with MIs, those with a low-risk lipoprotein profile for CHD, and those with NIDDM). Neither the number of affected vessels nor Gensini's scores differed among the genotype groups. Our case-control study in Japanese subjects did not show that the PON A/B polymorphism is associated with a risk of CHD.

References

Jul 29, 1991·FEBS Letters·M I MacknessP N Durrington
May 1, 1980·The New England Journal of Medicine·E A PhillipsB Clarkson
Jan 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·R A HegeleP W Connelly
Sep 17, 1994·Lancet·J L Witztum
Jan 1, 1993·Nature Genetics·R HumbertC E Furlong
Jun 1, 1993·Chemico-biological Interactions·M I MacknessP N Durrington
Dec 1, 1995·The Journal of Clinical Investigation·M Serrato, A J Marian

❮ Previous
Next ❯

Citations

Mar 5, 2004·International Journal of Cardiology·Simone A OliveiraJoyce M Annichino-Bizzacchi
Apr 17, 2003·Life Sciences·Noriyasu TanimotoKozo Hashimoto
Jun 16, 2000·International Journal of Cardiology·A S Aynacioglu, Y Kepekci
Nov 26, 1998·International Journal of Cardiology·N Pati, U Pati
Aug 14, 1998·General Pharmacology·B MacknessM I Mackness
Jan 5, 2000·European Journal of Clinical Investigation·B MacKnessA N Howard
Feb 26, 2010·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Gary GinsbergBabasaheb Sonawane
Jul 1, 2006·Fiziologiia cheloveka·v A Sukhanov, L A Piruzian
Sep 24, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·P M LaplaudM J Chapman
May 16, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Monique Vincent-VirySophie Visvikis
Oct 13, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Jelena Kotur-StevuljevicZorana Jelic-Ivanovic
Nov 21, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Eliane AlbuissonSophie Visvikis-Siest
Jul 27, 1999·Chemico-biological Interactions·L G CostaC E Furlong
Jul 27, 1999·Chemico-biological Interactions·M I MacknessB Mackness
Nov 25, 2000·Metabolism: Clinical and Experimental·M InoueK Hashimoto
Dec 23, 2009·Clinical Biochemistry·Randa H MohamedTarek A Abd El-Aziz
Jun 22, 1999·Toxicology and Applied Pharmacology·A S AynaciogluI Roots
Jun 25, 2016·Environmental Toxicology and Pharmacology·Siuli Mitra, Gautam K Kshatriya
Feb 4, 2005·Metabolism: Clinical and Experimental·Kikuko OtaKozo Hashimoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.